ABHD15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.499200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.018200E-01
Normal-vs-Stage2
5.897000E-01
Normal-vs-Stage3
1.281030E-01
Normal-vs-Stage4
6.164600E-01
Stage1-vs-Stage2
3.421800E-01
Stage1-vs-Stage3
2.556000E-01
Stage1-vs-Stage4
3.469600E-01
Stage2-vs-Stage3
2.108800E-01
Stage2-vs-Stage4
9.955600E-01
Stage3-vs-Stage4
2.382400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.224000E-01
Normal-vs-AfricanAmerican
4.051000E-01
Normal-vs-Asian
4.342600E-01
Caucasian-vs-AfricanAmerican
9.890000E-02
Caucasian-vs-Asian
8.985700E-02
AfricanAmerican-vs-Asian
7.448400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.642400E-01
Normal-vs-Female
9.261200E-01
Male-vs-Female
9.094000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.299400E-01
Normal-vs-Age(41-60Yrs)
7.801800E-01
Normal-vs-Age(61-80Yrs)
9.228400E-01
Normal-vs-Age(81-100Yrs)
3.416400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.645800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.181200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.878400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.753590E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.159800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.164360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.219580E-01
Normal-vs-Daily Drinker
8.687800E-01
Normal-vs-Weekly Drinker
2.053600E-01
Normal-vs-Occasional Drinker
7.266600E-01
Normal-vs-Social Drinker
8.029800E-01
Non Drinker-vs-Daily Drinker
1.478230E-01
Non Drinker-vs-Weekly Drinker
8.602200E-01
Non Drinker-vs-Occasional Drinker
1.362850E-01
Non Drinker-vs-Social Drinker
1.712830E-01
Daily Drinker-vs-Weekly Drinker
1.741170E-01
Daily Drinker-vs-Occasional Drinker
6.092800E-01
Daily Drinker-vs-Social Drinker
8.750800E-01
Weekly Drinker-vs-Occasional Drinker
1.493640E-01
Weekly Drinker-vs-Social Drinker
1.921620E-01
Occasional Drinker-vs-Social Drinker
7.435800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.478800E-01
Normal-vs-Grade 2
1.460790E-01
Normal-vs-Grade 3
1.748110E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.333800E-02
Grade 1-vs-Grade 3
4.533600E-02
Grade 1-vs-Grade 4
4.478800E-01
Grade 2-vs-Grade 3
5.740000E-01
Grade 2-vs-Grade 4
1.460790E-01
Grade 3-vs-Grade 4
1.748110E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.349600E-01
Normal-vs-NonDiabetic
8.879400E-01
Diabetic-vs-NonDiabetic
4.973200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.671200E-01
Normal-vs-NoPancreatitis
9.150400E-01
Pancreatitis-vs-NoPancreatitis
5.069800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.906400E-01
Normal-vs-N1
6.602000E-01
N0-vs-N1
2.964200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.080000E-01
Normal-vs-TP53-NonMutant
1.975780E-01
TP53-Mutant-vs-TP53-NonMutant
1.432010E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
